148 related articles for article (PubMed ID: 20452134)
21. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
22. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
Crane CH; Ellis LM; Abbruzzese JL; Amos C; Xiong HQ; Ho L; Evans DB; Tamm EP; Ng C; Pisters PW; Charnsangavej C; Delclos ME; O'Reilly M; Lee JE; Wolff RA
J Clin Oncol; 2006 Mar; 24(7):1145-51. PubMed ID: 16505434
[TBL] [Abstract][Full Text] [Related]
24. Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
Clément-Zhao A; Tanguy ML; Cottu P; De La Lande B; Bontemps P; Lemanski C; Baumann P; Savignoni A; Levy C; Peignaux K; Reynaud-Bougnoux A; Gobillion A; Kirova Y
PLoS One; 2019; 14(8):e0221816. PubMed ID: 31469859
[TBL] [Abstract][Full Text] [Related]
25. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
[TBL] [Abstract][Full Text] [Related]
26. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
Miller KD; Chap LI; Holmes FA; Cobleigh MA; Marcom PK; Fehrenbacher L; Dickler M; Overmoyer BA; Reimann JD; Sing AP; Langmuir V; Rugo HS
J Clin Oncol; 2005 Feb; 23(4):792-9. PubMed ID: 15681523
[TBL] [Abstract][Full Text] [Related]
27. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer.
Correa CR; Litt HI; Hwang WT; Ferrari VA; Solin LJ; Harris EE
J Clin Oncol; 2007 Jul; 25(21):3031-7. PubMed ID: 17634481
[TBL] [Abstract][Full Text] [Related]
28. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy.
Hanna YM; Baglan KL; Stromberg JS; Vicini FA; A Decker D
Breast J; 2002; 8(3):149-53. PubMed ID: 12047471
[TBL] [Abstract][Full Text] [Related]
29. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with pazopanib.
Goyal S; Shah S; Khan AJ; Danish H; Haffty BG
ISRN Oncol; 2012; 2012():896202. PubMed ID: 23304555
[TBL] [Abstract][Full Text] [Related]
31. Comparison of radiation-induced fatigue across 3 different radiotherapeutic methods for early stage breast cancer.
Taunk NK; Haffty BG; Chen S; Khan AJ; Nelson C; Pierce D; Goyal S
Cancer; 2011 Sep; 117(18):4116-24. PubMed ID: 21365631
[TBL] [Abstract][Full Text] [Related]
32. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
33. Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.
Koukourakis MI; Giatromanolaki A; Sheldon H; Buffa FM; Kouklakis G; Ragoussis I; Sivridis E; Harris AL;
Clin Cancer Res; 2009 Nov; 15(22):7069-76. PubMed ID: 19887481
[TBL] [Abstract][Full Text] [Related]
34. Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.
Cao L; Cai G; Chang C; Miao AY; Yu XL; Yang ZZ; Ma JL; Zhang Q; Wu J; Guo XM; Chen JY
Oncologist; 2015 Jun; 20(6):605-14. PubMed ID: 25933931
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
Stemmer SM; Pfeffer MR; Rizel S; Hardan I; Goffman J; Gezin A; Neumann A; Kitsios P; Alezra D; Brenner HJ
Cancer; 2001 Jun; 91(11):1983-91. PubMed ID: 11391576
[TBL] [Abstract][Full Text] [Related]
36. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer.
Wahl AO; Rademaker A; Kiel KD; Jones EL; Marks LB; Croog V; McCormick BM; Hirsch A; Karkar A; Motwani SB; Tereffe W; Yu TK; Sher D; Silverstein J; Kachnic LA; Kesslering C; Freedman GM; Small W
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):477-84. PubMed ID: 17869019
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results from AVADO.
Pivot X; Schneeweiss A; Verma S; Thomssen C; Passos-Coelho JL; Benedetti G; Ciruelos E; von Moos R; Chang HT; Duenne AA; Miles DW
Eur J Cancer; 2011 Nov; 47(16):2387-95. PubMed ID: 21757334
[TBL] [Abstract][Full Text] [Related]
38. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
de Gramont A; Van Cutsem E
Oncology; 2005; 69 Suppl 3():46-56. PubMed ID: 16301835
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
[TBL] [Abstract][Full Text] [Related]
40. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
